Phase 3 COVID Clinical Trials
31 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 31 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Pfizer300 enrolled132 locationsNCT07013474
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Phase 3
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Long COVID
Wes Ely550 enrolled16 locationsNCT06631287
Recruiting
Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
COVID
University of Minnesota820 enrolled66 locationsNCT04910269
Recruiting
Phase 2Phase 3
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Long COVIDSmell DysfunctionOlfactory Disorder
Medical University of South Carolina145 enrolled1 locationNCT05855369
Recruiting
Phase 3
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Long COVID
Douglas D. Fraser348 enrolled9 locationsNCT06928272
Recruiting
Phase 2Phase 3
Taurine Supplementation in Long COVID
Long COVID
University of Alberta300 enrolled5 locationsNCT06721949
Recruiting
Phase 3
Immunosuppression and COVID-19 Boosters
COVID-19
Kirby Institute320 enrolled5 locationsNCT05415267
Recruiting
Phase 2Phase 3
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
Post-Acute COVID-19 SyndromeLong COVIDPost-Acute COVID-19
Hellenic Institute for the Study of Sepsis182 enrolled24 locationsNCT05926505
Recruiting
Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
COVID-19
BioNTech SE25,500 enrolled208 locationsNCT07300839
Recruiting
Phase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Pfizer160 enrolled73 locationsNCT05261139
Recruiting
Phase 2Phase 3
A Study of Apabetalone in Subjects With Long -COVID
Post-Acute COVID-19 Syndrome
Resverlogix Corp200 enrolled3 locationsNCT06590324
Recruiting
Phase 2Phase 3
Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
COVID-19 Respiratory Infection
Peking Union Medical College Hospital1,096 enrolled1 locationNCT05689034
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Not Yet Recruiting
Phase 2Phase 3
Safety, tolerability and pharmacokinetics of SSTK-101 in healthy volunteers
Prevention of COVID 19
SKYDD Biotechnology Pty Ltd38 enrolled1 locationACTRN12624001064594
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707
Recruiting
Phase 3Phase 4
Intramuscular versus Subcutaneous COVID-19 needle length RCT
COVID-19
Medical Research Institute of New Zealand (MRINZ)400 enrolled1 locationACTRN12624000294550
Completed
Phase 3
Ivermectin to prevent Coronavirus
COVID-19
Monash University1,000 enrolled1 locationACTRN12621001535864
Terminated
Phase 3
Impact of Colchicine To Improve long-COVID-19 or ARDS Outcomes
COVID-19 Respiratory Infection
University of Sydney1,000 enrolled2 locationsACTRN12621000637842
Recruiting
Phase 2Phase 3
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
COVID
Tanta University300 enrolled1 locationNCT04351347